Article
Scenario drafting for early technology assessment of next generation sequencing in clinical oncology.
BMC cancer - 6 Feb 2016
Joosten S E P, Retèl V P, Coupé V M H, van den Heuvel M M, van Harten W H
Abstract excerpt
BACKGROUND: Next Generation Sequencing (NGS) is expected to lift molecular diagnostics in clinical oncology to the next level. It enables simultaneous identification of mutations in a patient tumor, after which targeted therapy may be assigned. This approach could improve patient survival and/or assist in controlling healthcare costs by offering expensive treatment to only those likely to benefit. However, NGS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.